--- title: Clinical Trials in Europe Show Promise for Treatment of COVID-19 description: As deaths from Covid-19 rise, it is clear no greater need exists than to see approval of life-saving treatments available to the worldwide market. image: https://www.oliverhcp.com/hubfs/01%20Blog%20Thumbs/Clinical%20Trial.jpg --- [Skip to Main Content](https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19#main-content) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) English ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 中文 - [PackTalk ](https://www.oliverhcp.com/packtalk/) - [ISO Certifications & Product Documents ](https://www.oliverhcp.com/iso-certifications-and-product-documents) [![Oliver_Logo_4clr_RGB_NoTag 1](https://www.oliverhcp.com/hubfs/Oliver_Logo_4clr_RGB_NoTag%201.svg "Oliver_Logo_4clr_RGB_NoTag 1")](https://oliverhcp.com) Toggle Menu Search Site Search Site Search [ Contact Us ](https://www.oliverhcp.com/contact) Phone Close **Website Settings** - No Animations [![](https://www.oliverhcp.com/hubfs/Oliver-logo-half.svg) ](https://www.oliverhcp.com/) [![](https://www.oliverhcp.com/hubfs/phone.svg) 833.465.4837](tel:833.465.4837) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) ENGLISH 中文 ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 [PackTalk](https://www.oliverhcp.com/packtalk/) SEARCH![](https://www.oliverhcp.com/hubfs/icon-search.svg) #### Expanded Stock Pouch Program ![](https://www.oliverhcp.com/hubfs/43.png) Expedited shipping from a partner you trust, now with more pouch options in a variety of sizes and materials. Don't let long lead times hold you back. Let Oliver help. [Learn More](https://www.oliverhcp.com/stockpouchprogram) [![logo-pack-talk-2](https://www.oliverhcp.com/hubfs/logo-pack-talk-2.svg) ](https://www.oliverhcp.com/packtalk/) # Clinical Trials in Europe Show Promise for Treatment of COVID-19 Oliver Healthcare Packaging Published on: 04/17/2020 Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) Roche Phase III Covid-19 clinical trial is under way, as United Kingdom Prime Minister Boris Johnson continues his recovery from the novel coronavirus. As the UK responds to high numbers and their own PM’s brush with death from Covid-19, it is clear no greater need exists than to see approval of life-saving treatments available to the worldwide market. Roche continues to be a major player as the pharmaceutical industry works with global regulatory leaders in the fight against the pandemic. In March, Pharma Times reported that Roche was approved (with French partner Sanofi, Eusa Pharma and US-based Regeneron) to undertake a Phase III clinical trial (COVACTA). Enrollment of 330 patients from across the world began in early April, with six patients enrolled to date from Spain and the US. Eligible patients must be hospitalized with “severe” Covid-19 pneumonia to be considered for the FDA-backed trial. ![Clinical Trial](https://www.oliverhcp.com/hubfs/01%20Blog%20Thumbs/Clinical%20Trial.jpg?quality=low) Actemra/RoActemra has previously been claimed as part of China’s Covid-19 treatment plan, published by the NHC on March 3, 2020. Existing independent studies for the drug’s use with Covid-19 patients offer limited published findings, such as a three-patient report of major improvement from a Naples, Italy hospital that was then tried at other Italian hospitals. This will be the first well-controlled, global study to clinically examine safety and efficacy. The trial paves the way to confirm or disprove Actemra/RoActemra as a viable treatment for patients suffering serious cases of Covid-19. Read more here: - [https://www.businessinsider.com/roche-actemra-coronavirus-trial-begins-enrolling-covid19-patients-2020-4](https://www.businessinsider.com/roche-actemra-coronavirus-trial-begins-enrolling-covid19-patients-2020-4) - [https://www.clinicaltrialsarena.com/comment/sanofi-partners-repurposed-antibodies-covid-19/](https://www.clinicaltrialsarena.com/comment/sanofi-partners-repurposed-antibodies-covid-19/) - [https://www.genengnews.com/virology/coronavirus/genentech-launches-phase-iii-trial-of-actemra-as-coronavirus-treatment/](https://www.genengnews.com/virology/coronavirus/genentech-launches-phase-iii-trial-of-actemra-as-coronavirus-treatment/)   Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/clinical-trials-in-europe-show-promise-for-treatment-of-covid-19) ## Stay up to date with PackTalk! FOLLOW US: [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/company/oliverhealthcarepackaging) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/oliverhcp/) [![](https://www.oliverhcp.com/hubfs/Content%20Hub/youtube.svg)](https://www.youtube.com/channel/UCzbJZ9TG2QK46F_EV-szUMg) ## Recently Published Articles [![](https://www.oliverhcp.com/hubfs/seal%20creep%20blog.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) ### [Investigating Seal Creep: Looking Beyond the Packaging](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) Lee Hyland ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Education Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/megan%20blog%206-23.jpg) ](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) ### [Preventing Packaging Failures with HDPE Cards](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) Christian Packard ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/Blog%20Image%20%286%29.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) ### [Australia’s Unique Device Identification Framework](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) Beryl Choo ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards Medical Device  — 3 minute read ## Contact Us ![](https://www.oliverhcp.com/hubfs/icon-mail-alt.svg) CONTACT US CHAT ![](https://dc.ads.linkedin.com/collect/?pid=94507&fmt=gif)